lilly trials retatrutide Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, is a triple hormone Retatrutide produces up to 30.3%

SLM+ contains rigorously vetted ingredients that can effectively support and enhance your weight loss journey, with ingredients that are not only pure but also potent

Published Phase 2 data (Jastreboff et al., NEJM 2023, N=338) demonstrated that Retatrutide at 12mg achieved 24.2% mean body weight reduction at 48 weeks surpassing Tirzepatides 22.5% achieved in 24 additional weeks

GLP-1s thus save lives and improve long-term cardiovascular outcomes, going well beyond glucose management

Like you I obviously know how long I was before I got very fat

Ro wins only when insurance pays the medication, which requires the PA process and the wait cost that comes with it

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating marketing campaigns, encouraging me to shed those last few pesky pounds via drugs, specifically off-label GLP-1